Collaboration announced for phase II study of larazotide for COVID-19-derived MIS-C Aug. 18, 2021 No Comments
Primary endpoint not met in phase II trial of trimodulin in patients with severe COVID-19 Aug. 16, 2021 No Comments
RSS